Urbana Campus Research Calendar (OVCRI)

View Full Calendar

Nuclear Receptors at the Intersection of Cancer and Engineering Symposium

Event Type
Seminar/Symposium
Sponsor
Cancer Center at Illinois
Location
Beckman Institute, 2nd Floor Tower Room 2269
Date
Sep 18, 2024   8:00 am - 5:00 pm  
Registration
Registration
Contact
Tyler Wolpert
E-Mail
wolpert1@illinois.edu
Views
78
Originating Calendar
Cancer Center Events

Overview

Please join us for a symposium on September 18: Nuclear Receptors at the Intersection of Cancer and Engineering Symposium.

NR IMPACT are a group of early to mid-stage researchers investigating nuclear receptor actions in health and disease. It was co-founded by Zeynep Madak-Erdogan. The science to be discussed will be exceptional. This is a great venue for trainees to network and establish potential connections for future postdoc opportunities.

Register Here

This event is co-hosted by the Cancer Center at Illinois and NR IMPACT. Sponsors include the School of Molecular & Cellular Biology, Department of Molecular & Integrative Physiology, and the Personalized Nutrition Initiative. 

Agenda

  • 8:00-8:15 a.m. | Welcome and Introductions
  • 8:45-9:15 a.m. | Katie Basham: Androgen Regulation of Anti-Tumor Immunity in Adrenal Cancer
  • 9:15-9:45 a.m. | Andrew Smith: Targeting Macrophage Nuclear Receptors with Translational Nanomaterials
  • 9:45-10:15 a.m. | Thu Truong: Progesterone Receptor as a Driver of Cancer Stem Cells in ER+ Breast Cancer
  • 10:15-10:30 a.m. | Coffee Break 
  • 10:30-11:00 a.m. | Chris Gaulke: Defining the Interplay Between the Microbiome and Nuclear Receptors in Gastrointestinal Carcinogenesis
  • 11:00-11:30 a.m. | Ray Blind: Novel Mechanisms of Activation and Ligands for the NR5A Nuclear Receptors SF-1 and LRH-1
  • 11:30 a.m.-12:00 p.m. | Susan Leggett: Mimicking Breast and Ovarian Cancer Spread on-a-Chip by Reverse-Engineering the 3D Tumor Microenvironment
  • 12:00-1:15 p.m. | Catered Lunch 
  • 1:15-1:45 p.m. | Steve Kregel: New Drivers of Castration Resistant Prostate Cancer That Will Knock Your SOX Off
  • 1:45-2:15 p.m. | Paul Hergenrother: Potent Compounds with Selectivity for Estrogen Receptor Positive Cancers  
  • 2:15-2:30 p.m. | Break 
  • 2:30-3:30 p.m. | Short Talks from Trainees 
  • 3:30-4:45 p.m. | Poster Session 
  • 4:45-5:00 p.m. | Awards Presentation
link for robots only